Fulcrum Therapeutics Inc. has granted a new employee 70,000 non-statutory stock options to purchase shares of the company’s common stock at an exercise price of $10.72 per share, the closing price on February 2, 2026. The stock options have a ten-year term and vest over four years, with 25% vesting on the first anniversary of the employee’s start date and the remaining shares vesting in equal quarterly installments over the following three years, contingent on continued employment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fulcrum Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9648249-en) on February 06, 2026, and is solely responsible for the information contained therein.